nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—SLC22A5—Dactinomycin—ocular cancer	0.406	1	CbGbCtD
Valproic Acid—HDAC9—cornea—ocular cancer	0.0686	0.394	CbGeAlD
Valproic Acid—SLC22A8—optic choroid—ocular cancer	0.0144	0.0828	CbGeAlD
Valproic Acid—OGDH—eye—ocular cancer	0.00959	0.055	CbGeAlD
Valproic Acid—OGDH—retina—ocular cancer	0.0095	0.0546	CbGeAlD
Valproic Acid—HDAC9—eye—ocular cancer	0.00845	0.0485	CbGeAlD
Valproic Acid—OGDH—lymphoid tissue—ocular cancer	0.00676	0.0388	CbGeAlD
Valproic Acid—HDAC9—lymphoid tissue—ocular cancer	0.00596	0.0342	CbGeAlD
Valproic Acid—ABAT—eye—ocular cancer	0.00574	0.0329	CbGeAlD
Valproic Acid—ABAT—retina—ocular cancer	0.00569	0.0326	CbGeAlD
Valproic Acid—ALDH5A1—lymphoid tissue—ocular cancer	0.00473	0.0271	CbGeAlD
Valproic Acid—HDAC2—eye—ocular cancer	0.00432	0.0248	CbGeAlD
Valproic Acid—HDAC2—retina—ocular cancer	0.00428	0.0246	CbGeAlD
Valproic Acid—HDAC2—epithelium—ocular cancer	0.00395	0.0227	CbGeAlD
Valproic Acid—SLC16A1—eye—ocular cancer	0.00384	0.022	CbGeAlD
Valproic Acid—SLC16A1—retina—ocular cancer	0.00381	0.0218	CbGeAlD
Valproic Acid—SLC16A1—epithelium—ocular cancer	0.00351	0.0202	CbGeAlD
Valproic Acid—HDAC2—lymphoid tissue—ocular cancer	0.00304	0.0175	CbGeAlD
Valproic Acid—SLC22A8—eye—ocular cancer	0.0029	0.0167	CbGeAlD
Valproic Acid—SLC22A5—retina—ocular cancer	0.00217	0.0125	CbGeAlD
Valproic Acid—PTGS1—epithelium—ocular cancer	0.00158	0.00905	CbGeAlD
Valproic Acid—CYP2B6—lymphoid tissue—ocular cancer	0.00134	0.00771	CbGeAlD
Valproic Acid—HDAC2—Cell Cycle—CDKN1A—ocular cancer	0.000531	0.00127	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of nuclear SMAD2/3 signaling—MYC—ocular cancer	0.00053	0.00126	CbGpPWpGaD
Valproic Acid—UGT1A6—NRF2 pathway—TGFB1—ocular cancer	0.000524	0.00125	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NOTCH—CCND1—ocular cancer	0.000521	0.00124	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—E2F3—ocular cancer	0.00051	0.00121	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.000509	0.00121	CbGpPWpGaD
Valproic Acid—HDAC2—Cell Cycle—EP300—ocular cancer	0.000506	0.0012	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—CDK4—ocular cancer	0.000494	0.00118	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—EIF1AX—ocular cancer	0.000491	0.00117	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—MDM2—ocular cancer	0.00049	0.00117	CbGpPWpGaD
Valproic Acid—CYP2A6—Fluoropyrimidine Activity—TP53—ocular cancer	0.000485	0.00115	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PSPH—ocular cancer	0.000483	0.00115	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NOTCH—EP300—ocular cancer	0.00048	0.00114	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TFDP1—ocular cancer	0.000474	0.00113	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PSPH—ocular cancer	0.00047	0.00112	CbGpPWpGaD
Valproic Acid—HDAC2—Chromatin modifying enzymes—CDK4—ocular cancer	0.000465	0.00111	CbGpPWpGaD
Valproic Acid—HDAC2—Notch Signaling Pathway—AKT1—ocular cancer	0.000461	0.0011	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—GNA11—ocular cancer	0.00046	0.00109	CbGpPWpGaD
Valproic Acid—ALDH5A1—Neuronal System—HRAS—ocular cancer	0.000445	0.00106	CbGpPWpGaD
Valproic Acid—HDAC2—Neural Crest Differentiation—MYC—ocular cancer	0.000444	0.00106	CbGpPWpGaD
Valproic Acid—ABAT—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00044	0.00105	CbGpPWpGaD
Valproic Acid—HDAC2—Cell Cycle—TGFB1—ocular cancer	0.00044	0.00105	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.000439	0.00105	CbGpPWpGaD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—TP53—ocular cancer	0.000431	0.00103	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—SAG—ocular cancer	0.000428	0.00102	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—GNAQ—ocular cancer	0.000427	0.00102	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of Telomerase—AKT1—ocular cancer	0.000423	0.00101	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—GNA11—ocular cancer	0.00042	0.001	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NOTCH—MYC—ocular cancer	0.000418	0.000995	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—CDKN1A—ocular cancer	0.000413	0.000983	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—E2F5—ocular cancer	0.000408	0.000973	CbGpPWpGaD
Valproic Acid—UGT1A4—NRF2 pathway—TGFB1—ocular cancer	0.000405	0.000964	CbGpPWpGaD
Valproic Acid—HDAC2—Factors involved in megakaryocyte development and platelet production—EP300—ocular cancer	0.000402	0.000957	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—E2F4—ocular cancer	0.0004	0.000953	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—HDAC1—ocular cancer	0.000393	0.000937	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—EP300—ocular cancer	0.000393	0.000935	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—RPL39—ocular cancer	0.000392	0.000934	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—RBL1—ocular cancer	0.000392	0.000934	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—GNAQ—ocular cancer	0.000391	0.000931	CbGpPWpGaD
Valproic Acid—SLC16A1—Cell surface interactions at the vascular wall—HRAS—ocular cancer	0.000388	0.000923	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—HDAC1—ocular cancer	0.000385	0.000917	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PSPH—ocular cancer	0.000382	0.000909	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—E2F5—ocular cancer	0.000379	0.000903	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MAML2—ocular cancer	0.000377	0.000897	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—E2F4—ocular cancer	0.000371	0.000885	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—GNA11—ocular cancer	0.000371	0.000884	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	0.000367	0.000875	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—RPL39—ocular cancer	0.000364	0.000868	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—RBL1—ocular cancer	0.000364	0.000868	CbGpPWpGaD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—AKT1—ocular cancer	0.000364	0.000867	CbGpPWpGaD
Valproic Acid—HDAC2—Cell Cycle—TP53—ocular cancer	0.000362	0.000862	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.000361	0.00086	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—CDKN2B—ocular cancer	0.000353	0.00084	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—HDAC1—ocular cancer	0.000352	0.000839	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—GNAQ—ocular cancer	0.000345	0.000822	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NOTCH—TP53—ocular cancer	0.000343	0.000817	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—RBBP4—ocular cancer	0.00034	0.00081	CbGpPWpGaD
Valproic Acid—ABAT—Neuronal System—HRAS—ocular cancer	0.000337	0.000803	CbGpPWpGaD
Valproic Acid—UGT1A3—NRF2 pathway—TGFB1—ocular cancer	0.000336	0.000801	CbGpPWpGaD
Valproic Acid—UGT1A9—PPARA activates gene expression—EP300—ocular cancer	0.000335	0.000799	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—GNA11—ocular cancer	0.000329	0.000783	CbGpPWpGaD
Valproic Acid—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	0.000328	0.000782	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—GNA11—ocular cancer	0.000324	0.000773	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—TFDP1—ocular cancer	0.000316	0.000753	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PSPH—ocular cancer	0.000311	0.000741	CbGpPWpGaD
Valproic Acid—CYP1A2—Tryptophan metabolism—MDM2—ocular cancer	0.000308	0.000733	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—GNAQ—ocular cancer	0.000306	0.000728	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—GNAQ—ocular cancer	0.000302	0.000718	CbGpPWpGaD
Valproic Acid—HDAC2—Chromatin modifying enzymes—CCND1—ocular cancer	0.0003	0.000715	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SAG—ocular cancer	0.0003	0.000715	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PSPH—ocular cancer	0.000294	0.000701	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—EP300—ocular cancer	0.000294	0.0007	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—TFDP1—ocular cancer	0.000294	0.000699	CbGpPWpGaD
Valproic Acid—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—ocular cancer	0.000287	0.000685	CbGpPWpGaD
Valproic Acid—UGT2B7—NRF2 pathway—TGFB1—ocular cancer	0.000286	0.000681	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.000281	0.000669	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.000281	0.000669	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—TP53—ocular cancer	0.000281	0.000669	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—MDM2—ocular cancer	0.000276	0.000659	CbGpPWpGaD
Valproic Acid—HDAC2—Chromatin modifying enzymes—EP300—ocular cancer	0.000276	0.000659	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HDAC1—ocular cancer	0.000275	0.000656	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—CDK2—ocular cancer	0.000273	0.000651	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—GNA11—ocular cancer	0.000271	0.000645	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—E2F5—ocular cancer	0.000265	0.000632	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—E2F4—ocular cancer	0.00026	0.00062	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.000259	0.000618	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RBL1—ocular cancer	0.000255	0.000608	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—CDKN1B—ocular cancer	0.000252	0.000601	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—GNAQ—ocular cancer	0.000252	0.0006	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MAML2—ocular cancer	0.000251	0.000598	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—CDK2—ocular cancer	0.00025	0.000595	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CDKN2B—ocular cancer	0.000247	0.000588	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.000247	0.000588	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.000247	0.000588	CbGpPWpGaD
Valproic Acid—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.000237	0.000566	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PSPH—ocular cancer	0.000237	0.000565	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—EP300—ocular cancer	0.000236	0.000562	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MAML2—ocular cancer	0.000233	0.000556	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—CDKN1A—ocular cancer	0.000233	0.000555	CbGpPWpGaD
Valproic Acid—UGT1A9—NRF2 pathway—TGFB1—ocular cancer	0.000232	0.000554	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PSPH—ocular cancer	0.000232	0.000553	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—E2F1—ocular cancer	0.000227	0.00054	CbGpPWpGaD
Valproic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	0.000226	0.000539	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—E2F3—ocular cancer	0.000221	0.000527	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.000215	0.000512	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.000214	0.000511	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—TP53—ocular cancer	0.00021	0.000501	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—GNA11—ocular cancer	0.000209	0.000498	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TFDP1—ocular cancer	0.000206	0.00049	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PSPH—ocular cancer	0.000201	0.000479	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—EP300—ocular cancer	0.000201	0.000478	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—MDM2—ocular cancer	0.000196	0.000466	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—GNAQ—ocular cancer	0.000194	0.000463	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—GNA11—ocular cancer	0.000186	0.000444	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—HDAC1—ocular cancer	0.000184	0.000437	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PSPH—ocular cancer	0.000179	0.000427	CbGpPWpGaD
Valproic Acid—CYP2A6—NRF2 pathway—TGFB1—ocular cancer	0.000179	0.000427	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—CDKN1B—ocular cancer	0.000179	0.000425	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—GNA11—ocular cancer	0.000174	0.000414	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—GNAQ—ocular cancer	0.000173	0.000413	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HDAC1—ocular cancer	0.000171	0.000406	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.000169	0.000402	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—CDKN1A—ocular cancer	0.000165	0.000393	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—CDKN2B—ocular cancer	0.000165	0.000392	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PSPH—ocular cancer	0.000164	0.000389	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MAML2—ocular cancer	0.000163	0.000389	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—GNAQ—ocular cancer	0.000162	0.000385	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—EP300—ocular cancer	0.000157	0.000373	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—EP300—ocular cancer	0.000154	0.000366	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CDKN2B—ocular cancer	0.000153	0.000364	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—GNA11—ocular cancer	0.000152	0.000362	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—HRAS—ocular cancer	0.000152	0.000361	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—GNA11—ocular cancer	0.000148	0.000352	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—AKT1—ocular cancer	0.000143	0.00034	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—GNA11—ocular cancer	0.000143	0.000339	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—GNAQ—ocular cancer	0.000141	0.000336	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—EP300—ocular cancer	0.00014	0.000335	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PSPH—ocular cancer	0.00014	0.000333	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—GNAQ—ocular cancer	0.000137	0.000327	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MDM2—ocular cancer	0.000137	0.000326	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—MYC—ocular cancer	0.000137	0.000325	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—TGFB1—ocular cancer	0.000136	0.000325	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—AKT1—ocular cancer	0.000134	0.000319	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TGFB1—ocular cancer	0.000133	0.000318	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—GNAQ—ocular cancer	0.000132	0.000316	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CDKN1B—ocular cancer	0.000125	0.000298	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—EP300—ocular cancer	0.000124	0.000295	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TGFB1—ocular cancer	0.000122	0.000291	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—AKT1—ocular cancer	0.000121	0.000289	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GNA11—ocular cancer	0.00012	0.000286	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HDAC1—ocular cancer	0.000119	0.000284	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCND1—ocular cancer	0.000119	0.000284	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CDKN1A—ocular cancer	0.000115	0.000275	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GNAQ—ocular cancer	0.000112	0.000266	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TP53—ocular cancer	0.00011	0.000262	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—EP300—ocular cancer	0.00011	0.000262	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—EP300—ocular cancer	0.000108	0.000258	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PSPH—ocular cancer	0.000108	0.000257	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—HRAS—ocular cancer	0.000107	0.000256	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CDKN2B—ocular cancer	0.000107	0.000255	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—HRAS—ocular cancer	0.000105	0.00025	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TP53—ocular cancer	0.0001	0.000239	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—E2F1—ocular cancer	9.83e-05	0.000234	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GNA11—ocular cancer	9.79e-05	0.000233	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—HRAS—ocular cancer	9.61e-05	0.000229	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MYC—ocular cancer	9.57e-05	0.000228	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TGFB1—ocular cancer	9.54e-05	0.000227	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—AKT1—ocular cancer	9.47e-05	0.000226	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—AKT1—ocular cancer	9.28e-05	0.000221	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GNA11—ocular cancer	9.26e-05	0.00022	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GNAQ—ocular cancer	9.1e-05	0.000217	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—EP300—ocular cancer	9.05e-05	0.000215	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	9.01e-05	0.000215	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GNAQ—ocular cancer	8.6e-05	0.000205	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—AKT1—ocular cancer	8.49e-05	0.000202	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MDM2—ocular cancer	8.48e-05	0.000202	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TP53—ocular cancer	7.86e-05	0.000187	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CDKN1B—ocular cancer	7.74e-05	0.000184	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HRAS—ocular cancer	7.51e-05	0.000179	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—AKT1—ocular cancer	7.49e-05	0.000178	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GNA11—ocular cancer	7.47e-05	0.000178	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	7.34e-05	0.000175	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GNA11—ocular cancer	7.3e-05	0.000174	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CDKN1A—ocular cancer	7.15e-05	0.00017	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—EP300—ocular cancer	6.98e-05	0.000166	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GNAQ—ocular cancer	6.94e-05	0.000165	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—EP300—ocular cancer	6.8e-05	0.000162	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GNAQ—ocular cancer	6.79e-05	0.000162	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—AKT1—ocular cancer	6.63e-05	0.000158	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—AKT1—ocular cancer	6.55e-05	0.000156	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MYC—ocular cancer	6.38e-05	0.000152	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GNA11—ocular cancer	6.32e-05	0.000151	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—EP300—ocular cancer	6.23e-05	0.000148	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MDM2—ocular cancer	5.94e-05	0.000141	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MYC—ocular cancer	5.92e-05	0.000141	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—TGFB1—ocular cancer	5.91e-05	0.000141	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GNAQ—ocular cancer	5.88e-05	0.00014	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—EP300—ocular cancer	5.81e-05	0.000138	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GNA11—ocular cancer	5.64e-05	0.000134	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—AKT1—ocular cancer	5.47e-05	0.00013	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CDKN1B—ocular cancer	5.42e-05	0.000129	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GNAQ—ocular cancer	5.25e-05	0.000125	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCND1—ocular cancer	5.17e-05	0.000123	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GNA11—ocular cancer	5.15e-05	0.000123	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—EP300—ocular cancer	5.07e-05	0.000121	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CDKN1A—ocular cancer	5e-05	0.000119	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—EP300—ocular cancer	4.94e-05	0.000118	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GNAQ—ocular cancer	4.78e-05	0.000114	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EP300—ocular cancer	4.76e-05	0.000113	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	4.74e-05	0.000113	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HRAS—ocular cancer	4.65e-05	0.000111	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—AKT1—ocular cancer	4.42e-05	0.000105	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GNA11—ocular cancer	4.4e-05	0.000105	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	4.23e-05	0.000101	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—AKT1—ocular cancer	4.22e-05	0.000101	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MYC—ocular cancer	4.15e-05	9.88e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TGFB1—ocular cancer	4.14e-05	9.86e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—AKT1—ocular cancer	4.11e-05	9.79e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GNAQ—ocular cancer	4.09e-05	9.74e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—EP300—ocular cancer	4.01e-05	9.56e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.86e-05	9.2e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—AKT1—ocular cancer	3.76e-05	8.96e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—AKT1—ocular cancer	3.51e-05	8.36e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—ocular cancer	3.41e-05	8.12e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GNA11—ocular cancer	3.39e-05	8.08e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.3e-05	7.86e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—EP300—ocular cancer	3.27e-05	7.79e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HRAS—ocular cancer	3.26e-05	7.76e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GNAQ—ocular cancer	3.15e-05	7.52e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—EP300—ocular cancer	3.09e-05	7.37e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—AKT1—ocular cancer	3.07e-05	7.31e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—AKT1—ocular cancer	2.98e-05	7.11e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AKT1—ocular cancer	2.88e-05	6.85e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—EP300—ocular cancer	2.5e-05	5.94e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—EP300—ocular cancer	2.44e-05	5.81e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—AKT1—ocular cancer	2.42e-05	5.77e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—EP300—ocular cancer	2.11e-05	5.03e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—AKT1—ocular cancer	1.98e-05	4.71e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—EP300—ocular cancer	1.89e-05	4.49e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—AKT1—ocular cancer	1.87e-05	4.45e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—EP300—ocular cancer	1.72e-05	4.1e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AKT1—ocular cancer	1.51e-05	3.59e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AKT1—ocular cancer	1.47e-05	3.51e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—EP300—ocular cancer	1.47e-05	3.5e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKT1—ocular cancer	1.28e-05	3.04e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKT1—ocular cancer	1.14e-05	2.71e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—EP300—ocular cancer	1.13e-05	2.7e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKT1—ocular cancer	1.04e-05	2.47e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKT1—ocular cancer	8.88e-06	2.11e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKT1—ocular cancer	6.85e-06	1.63e-05	CbGpPWpGaD
